Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 02 November 2020 |
| Author/s |
author: Ana C Garrido-Castro Aleix Prat Ian E Krop Romualdo Barroso-Sousa Nancy U Lin Eric Winer Gordon B. Mills |
| Publication date | November 2, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |